Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type (Organoids and Spheroids), Application, End Use, and Region; Segment Forecasts, 2026-2034

Description

List of Tables

The global organoids and spheroids market size is expected to reach USD 13.99 billion by 2034, according to a new study by Polaris Market Research. The report "Organoids and Spheroids Market Share, Size, Trends, Industry Analysis Report - By Type, Application, End Use, and Region; Segment Forecasts, 2026-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The development of genetic editing techniques such as CRISPR/Cas-9 has enabled researchers to make precise changes to genes in stem cells, leading to the creation of organoids and spheroids that replicate disease conditions. These advancements have provided researchers with improved models for studying diseases and testing drugs, yielding valuable insights into complex cellular conditions. The combination of progress in stem cell technology and 3D culture methods has played a crucial role in the steady growth of the organoids and spheroids market. In January 2024, USC researchers developed a new human brain organoid model to study cerebellum development and the emergence of cerebellar pathology in neurological disease.

Patient-specific organoids represent a robust platform for advancing personalized medicine and driving the growth of the organoids and spheroids market by enabling the testing of potential drugs on tissues sourced from patients, which provides valuable insights into individual therapy responses. The clinical importance of organoids and spheroids in both research and clinical practice is crucial for developing personalized organoid models and furthering the progress of P4 medicine.

The development of 3D bioprinting technologies and organ-on-a-chip platforms significantly advances organoid and spheroid research. 3D bioprinting enables the creation of complex, customized tissue models with high precision, enhancing drug testing and personalized medicine. Organ-on-a-chip platforms replicate organ functions in miniature, allowing for dynamic modeling, high-throughput screening, and personalized treatment strategies. Together, these innovations improve the accuracy and relevance of biomedical research, facilitating more effective drug development and disease understanding.

Organoids and Spheroids Market Report Highlights

Based on type, the spheroids segment held a larger share in 2025, owing to their significant use in drug discovery and disease modeling.

The organoids segment is projected to grow rapidly during the forecast period, fueled by rising occurrences of diseases such as cancer, neurodegenerative disorders, and infectious diseases, driving demand for advanced research models.

By application, the developmental biology segment dominated the market in 2025, owing to its application in the mechanism of organogenesis.

North America holds the largest share in 2025, owing to the rising use of organoids and spheroids for personalized medicine.

A few key players are 3D Biomatrix, 3D Biotek, AMS Biotechnology, Cellesce, Greiner Bio-One, and Thermo Fisher Scientific.

Polaris Market Research has segmented the organoids and spheroids market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue - USD billion, 2021-2034)

Organoids

By Type

Neural Organoids

Hepatic Organoids

Intestinal Organoids

Other Organoids

By Method

General Submerged Method for Organoid Culture

Crypt Organoid Culture Techniques

Air Liquid Interface (ALI) Method for Organoid Culture

Clonal Organoids from Lgr5+ Cells

Brain and Retina Organoid Formation Protocol

Others

By Source

Primary Tissues

Stem Cells

Spheroids

By Type

Multicellular Tumor Spheroids (MCTS)

Neurospheres

Mammospheres

Hepatospheres

Embryoid Bodies

By Method

Micropatterned Plates

Low Cell Attachment Plates

Hanging Drop Method

Others

By Source

Cell Line

Primary Cell

iPSCs Derived Cells

By Application Outlook (Revenue - USD billion, 2021-2034)

Developmental Biology

Personalized Medicine

Regenerative Medicine

Disease Pathology Studies

Drug Toxicity & Efficacy Testing

By End Use Outlook (Revenue - USD billion, 2021-2034)

Biotechnology & Pharmaceutical Industries

Academic & Research Institutes

Hospitals & Diagnostic Centers

By Regional Outlook (Revenue - USD billion, 2021-2034)

North America

Canada

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Product Code: PM1782

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. Global Organoids and Spheroids Market Insights

4.1. Organoids and Spheroids Market - Market Snapshot
4.2. Organoids and Spheroids Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Advancement in stem cell research
  - 4.2.1.2. Increased application in drug discovery and personalized medicine
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High cost of development and Production
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Organoids and Spheroids Market Application Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis

5. Global Organoids and Spheroids Market, by Type

5.1. Key Findings
5.2. Introduction
- 5.2.1. Global Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
5.3. Organoids
- 5.3.1. Global Organoids and Spheroids Market, by Organoids, by Region, 2021-2034 (USD Billion)
5.4. Spheroids
- 5.4.1. Global Organoids and Spheroids Market, by Spheroids, by Region, 2021-2034 (USD Billion)

6. Global Organoids and Spheroids Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. Global Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
6.3. Developmental Biology
- 6.3.1. Global Organoids and Spheroids Market, by Developmental Biology, by Region, 2021-2034 (USD Billion)
6.4. Personalized Medicine
- 6.4.1. Global Organoids and Spheroids Market, by Personalized Medicine, by Region, 2021-2034 (USD Billion)
6.5. Regenerative Medicine
- 6.5.1. Global Organoids and Spheroids Market, by Regenerative Medicine, by Region, 2021-2034 (USD Billion)
6.6. Disease Pathology Studies
- 6.6.1. Global Organoids and Spheroids Market, by Disease Pathology Studies, by Region, 2021-2034 (USD Billion)
6.7. Drug Toxicity & Efficacy Testing
- 6.7.1. Global Organoids and Spheroids Market, by Drug Toxicity & Efficacy Testing, by Region, 2021-2034 (USD Billion)

7. Global Organoids and Spheroids Market, by End Use

7.1. Key Findings
7.2. Introduction
- 7.2.1. Global Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
7.3. Biotechnology & Pharmaceutical Industries
- 7.3.1. Global Organoids and Spheroids Market, by Biotechnology & Pharmaceutical Industries, by Region, 2021-2034 (USD Billion)
7.4. Academic & Research Institutes
- 7.4.1. Global Organoids and Spheroids Market, by Academic & Research Institutes, by Region, 2021-2034 (USD Billion)
7.5. Hospitals & Diagnostic Centers
- 7.5.1. Global Organoids and Spheroids Market, by Hospitals & Diagnostic Centers, by Region, 2021-2034 (USD Billion)

8. Global Organoids and Spheroids Market, by Geography

8.1. Key Findings
8.2. Introduction
- 8.2.1. Organoids and Spheroids Market Assessment, By Geography, 2021-2034 (USD Billion)
8.3. Organoids and Spheroids Market - North America
- 8.3.1. North America: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
- 8.3.2. North America: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
- 8.3.3. North America: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.3.4. Organoids and Spheroids Market - U.S.
  - 8.3.4.1. U.S.: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.3.4.2. U.S.: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.3.4.3. U.S.: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.3.5. Organoids and Spheroids Market - Canada
  - 8.3.5.1. Canada: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.3.5.2. Canada: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.3.5.3. Canada: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
8.4. Organoids and Spheroids Market - Europe
- 8.4.1. Europe: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
- 8.4.2. Europe: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
- 8.4.3. Europe: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.4. Organoids and Spheroids Market - UK
  - 8.4.4.1. UK: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.4.2. UK: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.4.3. UK: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.5. Organoids and Spheroids Market - France
  - 8.4.5.1. France: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.5.2. France: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.5.3. France: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.6. Organoids and Spheroids Market - Germany
  - 8.4.6.1. Germany: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.6.2. Germany: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.6.3. Germany: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.7. Organoids and Spheroids Market - Italy
  - 8.4.7.1. Italy: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.7.2. Italy: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.7.3. Italy: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.8. Organoids and Spheroids Market - Spain
  - 8.4.8.1. Spain: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.8.2. Spain: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.8.3. Spain: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.9. Organoids and Spheroids Market - Netherlands
  - 8.4.9.1. Netherlands: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.9.2. Netherlands: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.9.3. Netherlands: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.10. Organoids and Spheroids Market - Russia
  - 8.4.10.1. Russia: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.10.2. Russia: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.10.3. Russia: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.4.11. Organoids and Spheroids Market - Rest of Europe
  - 8.4.11.1. Rest of Europe: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.4.11.2. Rest of Europe: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.4.11.3. Rest of Europe: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
8.5. Organoids and Spheroids Market - Asia Pacific
- 8.5.1. Asia Pacific: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
- 8.5.2. Asia Pacific: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
- 8.5.3. Asia Pacific: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.4. Organoids and Spheroids Market - China
  - 8.5.4.1. China: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.4.2. China: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.4.3. China: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.5. Organoids and Spheroids Market - India
  - 8.5.5.1. India: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.5.2. India: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.5.3. India: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.6. Organoids and Spheroids Market - Malaysia
  - 8.5.6.1. Malaysia: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.6.2. Malaysia: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.6.3. Malaysia: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.7. Organoids and Spheroids Market - Japan
  - 8.5.7.1. Japan: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.7.2. Japan: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.7.3. Japan: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.8. Organoids and Spheroids Market - Indonesia
  - 8.5.8.1. Indonesia: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.8.2. Indonesia: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.8.3. Indonesia: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.9. Organoids and Spheroids Market - South Korea
  - 8.5.9.1. South Korea: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.9.2. South Korea: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.9.3. South Korea: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.10. Organoids and Spheroids Market - Australia
  - 8.5.10.1. Australia: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.10.2. Australia: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.10.3. Australia: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.5.11. Organoids and Spheroids Market - Rest of Asia Pacific
  - 8.5.11.1. Rest of Asia Pacific: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.5.11.2. Rest of Asia Pacific: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.5.11.3. Rest of Asia Pacific: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
8.6. Organoids and Spheroids Market - Middle East & Africa
- 8.6.1. Middle East & Africa: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
- 8.6.2. Middle East & Africa: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
- 8.6.3. Middle East & Africa: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.6.4. Organoids and Spheroids Market - Saudi Arabia
  - 8.6.4.1. Saudi Arabia: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.6.4.2. Saudi Arabia: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.6.4.3. Saudi Arabia: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.6.5. Organoids and Spheroids Market - UAE
  - 8.6.5.1. UAE: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.6.5.2. UAE: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.6.5.3. UAE: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.6.6. Organoids and Spheroids Market - Israel
  - 8.6.6.1. Israel: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.6.6.2. Israel: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.6.6.3. Israel: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.6.7. Organoids and Spheroids Market - South Africa
  - 8.6.7.1. South Africa: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.6.7.2. South Africa: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.6.7.3. South Africa: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.6.8. Organoids and Spheroids Market - Rest of Middle East & Africa
  - 8.6.8.1. Rest of Middle East & Africa: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.6.8.2. Rest of Middle East & Africa: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.6.8.3. Rest of Middle East & Africa: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
8.7. Organoids and Spheroids Market - Latin America
- 8.7.1. Latin America: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
- 8.7.2. Latin America: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
- 8.7.3. Latin America: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.7.4. Organoids and Spheroids Market - Mexico
  - 8.7.4.1. Mexico: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.7.4.2. Mexico: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.7.4.3. Mexico: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.7.5. Organoids and Spheroids Market - Brazil
  - 8.7.5.1. Brazil: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.7.5.2. Brazil: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.7.5.3. Brazil: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.7.6. Organoids and Spheroids Market - Argentina
  - 8.7.6.1. Argentina: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.7.6.2. Argentina: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.7.6.3. Argentina: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)
- 8.7.7. Organoids and Spheroids Market - Rest of Latin America
  - 8.7.7.1. Rest of Latin America: Organoids and Spheroids Market, by Type, 2021-2034 (USD Billion)
  - 8.7.7.2. Rest of Latin America: Organoids and Spheroids Market, by Application, 2021-2034 (USD Billion)
  - 8.7.7.3. Rest of Latin America: Organoids and Spheroids Market, by End Use, 2021-2034 (USD Billion)

9. Competitive Landscape

9.1. Expansion and Acquisition Analysis
- 9.1.1. Expansion
- 9.1.2. Acquisitions
9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

10.1. 3D Biomatrix
- 10.1.1. Company Overview
- 10.1.2. Financial Performance
- 10.1.3. Type Benchmarking
- 10.1.4. Recent Development
10.2. 3D Biotek LLC
- 10.2.1. Company Overview
- 10.2.2. Financial Performance
- 10.2.3. Type Benchmarking
- 10.2.4. Recent Development
10.3. AMS Biotechnology Limited
- 10.3.1. Company Overview
- 10.3.2. Financial Performance
- 10.3.3. Type Benchmarking
- 10.3.4. Recent Development
10.4. Cellesce Ltd.
- 10.4.1. Company Overview
- 10.4.2. Financial Performance
- 10.4.3. Type Benchmarking
- 10.4.4. Recent Development
10.5. TheWell Bioscience
- 10.5.1. Company Overview
- 10.5.2. Financial Performance
- 10.5.3. Type Benchmarking
- 10.5.4. Recent Development
10.6. Greiner Bio-One
- 10.6.1. Company Overview
- 10.6.2. Financial Performance
- 10.6.3. Type Benchmarking
- 10.6.4. Recent Development
10.7. Hubrecht Organoid Technology (HUB)
- 10.7.1. Company Overview
- 10.7.2. Financial Performance
- 10.7.3. Type Benchmarking
- 10.7.4. Recent Development
10.8. InSphero
- 10.8.1. Company Overview
- 10.8.2. Financial Performance
- 10.8.3. Type Benchmarking
- 10.8.4. Recent Development
10.9. Lonza
- 10.9.1. Company Overview
- 10.9.2. Financial Performance
- 10.9.3. Type Benchmarking
- 10.9.4. Recent Development
10.10. Merck KGaA
- 10.10.1. Company Overview
- 10.10.2. Financial Performance
- 10.10.3. Type Benchmarking
- 10.10.4. Recent Development
10.11. Prellis Biologics
- 10.11.1. Company Overview
- 10.11.2. Financial Performance
- 10.11.3. Type Benchmarking
- 10.11.4. Recent Development
10.12. STEMCELL Technologies Inc.
- 10.12.1. Company Overview
- 10.12.2. Financial Performance
- 10.12.3. Type Benchmarking
- 10.12.4. Recent Development
10.13. Thermo Fisher Scientific, Inc.
- 10.13.1. Company Overview
- 10.13.2. Financial Performance
- 10.13.3. Type Benchmarking
- 10.13.4. Recent Development